On the other hand, it has been reported that the loss of wild-type p53 is an important prerequisite for the stabilization of mutant p53 in breast cancer and sarcomas, suggesting that chimeric p53 tetramers are not stable in these cells (Alexandrova et al., 2017). The gene discussed is TP53; the disease is sarcoma.